Department of Medicine
University of Washington, USA
Dr. Ru Chen received her PhD from University of Washington, and had post-doctoral training at the University of Washington and Institute for Systems Biology, where she had extensive training in mass spectrometry-based proteomics and applied these technologies to study pancreatic cancer.
Dr. Ru Chen is on pancreatic cancer which is a uniformly lethal disease which is difficult to diagnose at early stage and even more difficult to cure. Earlier diagnosis and better treatments are desperately needed to improve the survival rate of pancreatic cancer patients. With the goals of improving current diagnosis and treatment for pancreatic cancer, her research area centers around two aspects: 1) discovery of protein biomarkers for early detection of pancreatic cancer. The aim is to identify candidate biomarkers directly from serum, pancreatic cancer tissue and pancreatic juice using recently developed proteomics tools 2) study of the molecular mechanisms underlying pancreatic tumorigenesis. Our understanding of how cancer develops is a fundamental key to the successful selection of early biomarkers of disease and future advancement of chemotherapeutic targets.